Skip to Main Content

Author Details

Reza Ghasemi
Washington University School of Medicine
2003
26
12
PMIDPaper TitleJournal TitlePublished Year
37079859Persistent Molecular Disease in Adult Patients With AML Evaluated With Whole-Exome and Targeted Error-Corrected DNA Sequencing.JCO Precis Oncol2023
37200687The Functionality of Apigenin as a Novel Cardioprotective Nutraceutical with Emphasize on Regulating Cardiac Micro RNAs:.Galen Med J2022
32398790Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cells.Leukemia2021
32754433Comparison of Patient's Kidney Function Based on Kidney Disease Improving Global Outcomes (KDIGO) Criteria and Clinical Parameters in Isolated Coronary Artery Bypass Graft (CABG) Surgery in On-Pump and Off-pump Methods in Patients with Low Cardiac Output Syndrome (LCOS) After Surgery.Anesth Pain Med2020
33889190The effect of calcium in water hardness on digoxin plasma levels in an experimental rat model.ARYA Atheroscler2020
29663541Eccentric exercise increases circulating fibroblast activation protein α but not bioactive fibroblast growth factor 21 in healthy humans.Exp Physiol2018
30108642Trifascicular block as primary presentation of the cardiac amyloidosis; A rare case report.ARYA Atheroscler2018
30584563Quetiapine versus Haloperidol in Controlling Conversion Disorder Symptoms; a Randomized Clinical Trial.Emerg (Tehran)2018
28345160Increasing skeletal muscle carnitine availability does not alter the adaptations to high-intensity interval training.Scand J Med Sci Sports2018
27834660Private and Efficient Query Processing on Outsourced Genomic Databases.IEEE J Biomed Health Inform2017
28344875Targeting of IL-2 to cytotoxic lymphocytes as an improved method of cytokine-driven immunotherapy.Oncoimmunology2017
28646172Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells.Sci Rep2017
28786364Aftermath of bustamante attack on genomic beacon service.BMC Med Genomics2017
27120784Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.Oncotarget2016
28123874Deficiency of the adaptor protein SLy1 results in a natural killer cell ribosomopathy affecting tumor clearance.Oncoimmunology2016
28607569Huge mass in right side of the heart: A rare case report.ARYA Atheroscler2016
26482609Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway.Tumour Biol2016
27650575Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy.Nat Commun2016
25133484Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer.Oncogenesis2014
25178039Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer.Oncogenesis2014
23177570Tumor-derived microvesicles: the metastasomes.Med Hypotheses2013
24466370EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo.Transl Oncol2013
23659451Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells.Nutr Cancer2013
19763917Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.Med Oncol2010
20166242Silibinin inhibits invasive properties of human glioblastoma U87MG cells through suppression of cathepsin B and nuclear factor kappa B-mediated induction of matrix metalloproteinase 9.Anticancer Drugs2010
14505889A simple mistake responsible for 153 cases of muscular cold abscesses.Vaccine2003
  • 1 - 26 of 26

Recommended Authors

Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 0
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 0
Ke Jin
West China Hospital, Sichuan University
Career Start Year 2005
Number of shared co-authors 0
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Christopher J Howlett
Western University
Career Start Year 1999
Number of shared co-authors 0
Feng Zhu
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 0
Rong Fan
Institute of Pathogens and Vectors, Dali University
Career Start Year 1998
Number of shared co-authors 0
Ji Eun Oh
College of Science & Industry Convergence, Ewha Womans University
Career Start Year 1997
Number of shared co-authors 0
Nan Wu
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year 1997
Number of shared co-authors 0
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Hyo Jin Kim
Department of Food Bioengineering, Jeju National University
Career Start Year 1996
Number of shared co-authors 0
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Nam Bui
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Ning Guo
Beijing Tongren Hospital, Capital Medical University
Career Start Year 1995
Number of shared co-authors 0
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1989
Number of shared co-authors 0
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 0
Sun Young Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1988
Number of shared co-authors 0
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 0

Collaborators

David H Spencer
Washington University School of Medicine.
Co-authored papers 2
Noman Mohammed
University of Manitoba
Co-authored papers 2
Md Momin Al Aziz
University of Manitoba
Co-authored papers 2
Xiaoqian Jiang
Carnegie Mellon University, The University of Texas Health Science Center at Houston, University of California San Diego
Co-authored papers 1
Michelle O'Laughlin
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 1
Massoud Hadian Dehkordi
Co-authored papers 1
Leonard B Maggi
Washington University School of Medicine
Co-authored papers 1
Timothy J Ley
Washington University School of Medicine
Co-authored papers 1
Robert S Fulton
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 1
Wayne M Yokoyama
Co-authored papers 1
Release 1.2